Alpine Global Management, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Alpine Global Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$127.18 - $173.91 $805,558 - $1.1 Million	-6,334 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$159.56 - $209.29 $1.01 Million - $1.33 Million	6,334 New	6,334 $1.07 Million
Q4 2017 Feb 14, 2018	SELL	$114.49 - $139.98 $848,370 - $1.04 Million	-7,410 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$72.53 - $118.27 $537,447 - $876,380	7,410	7,410 $871,000

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.